{"id":166316,"date":"2025-11-06T16:20:08","date_gmt":"2025-11-06T16:20:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/166316\/"},"modified":"2025-11-06T16:20:08","modified_gmt":"2025-11-06T16:20:08","slug":"texas-seeks-to-block-kenvue-dividend-amid-tylenol-lawsuit","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/166316\/","title":{"rendered":"Texas seeks to block Kenvue dividend amid Tylenol lawsuit"},"content":{"rendered":"<ul data-testid=\"Summary\" class=\"summary-module__summary__QjADA\">\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Texas attorney general says Kenvue should conserve cash<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Nearly $400 million payout planned for November 26<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Lawsuit claims Kenvue, J&amp;J hid Tylenol link to autism<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Kenvue agreed to Kimberly-Clark takeover<\/li>\n<li data-testid=\"Body\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf summary-module__point__UgXPz\">Kenvue not immediately available for comment<\/li>\n<\/ul>\n<p>Nov 6 (Reuters) &#8211; Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/KVUE.N\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(KVUE.N), opens new tab<\/a> from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from the use of Tylenol by pregnant women.The October 28 lawsuit against Kenvue and its former parent Johnson &amp; Johnson <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/JNJ.N\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(JNJ.N), opens new tab<\/a>, which made Tylenol for six decades, was filed five weeks after Republican <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/trump-expected-link-autism-with-tylenol-experts-say-more-research-needed-2025-09-22\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">President Donald Trump<\/a> repeated the unproven claim that using Tylenol during pregnancy can cause autism.<\/p>\n<p data-testid=\"promo-box\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__promo-box__hVl8h\"> Sign up  <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/world\/texas-seeks-block-kenvue-dividend-amid-tylenol-lawsuit-2025-11-06\/undefined?location=article-paragraph&amp;redirectUrl=%2Fworld%2Ftexas-seeks-block-kenvue-dividend-amid-tylenol-lawsuit-2025-11-06%2F\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">here.<\/a><\/p>\n<p>Paxton, also a Republican, said Kenvue must conserve cash because it faces billions of dollars of potential damages related both to Tylenol and to international lawsuits claiming that baby powder containing talc causes cancer.<\/p>\n<p>He is seeking an injunction against paying the scheduled November 26 dividend, saying it would violate a Texas law against fraudulent transfers. The dividend would total about $398 million, according to a regulatory filing.<\/p>\n<p>&#8220;Kenvue very well may be insolvent because of its own reckless actions,&#8221; Paxton said. &#8220;It is hard to think of a more classic example of a fraudulent transfer than this.&#8221;<\/p>\n<p>Doctors and medical societies consider acetaminophen products such as Tylenol the <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/is-tylenol-safe-take-during-pregnancy-2025-09-22\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">best option<\/a> for treating fever and pain during pregnancy.<\/p>\n<p>Kenvue has repeatedly defended Tylenol&#8217;s safety. The Summit, New Jersey-based company did not immediately respond to requests for comment. Johnson &amp; Johnson declined to comment.<\/p>\n<p>LITIGATION WEIGHS OVER PROPOSED KENVUE TAKEOVERPaxton&#8217;s request for an injunction complicates Kimberly-Clark&#8217;s <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/markets\/companies\/KMB.O\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">(KMB.O), opens new tab<\/a> <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/kimberly-clark-acquire-kenvue-487-billion-deal-2025-11-03\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">planned $40 billion takeover<\/a> of Kenvue.The merger was announced on Monday. If completed it would let the maker of Kleenex and Huggies diapers expand into <a data-testid=\"Link\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/kimberly-clarks-50-billion-leap-into-health-beauty-tests-investor-faith-2025-11-03\/\" class=\"text-module__text__0GDob text-module__inherit-color__PhuPF text-module__inherit-font__1P1hv text-module__inherit-size__EyiQW link-module__link__INqxZ link-module__underline_default__-okuC\" rel=\"nofollow noopener\" target=\"_blank\">higher-margin categories<\/a> such as skin care and pain relief.<\/p>\n<p>Band-Aid, Johnson&#8217;s Baby shampoo, Listerine and Neutrogena are some of Kenvue&#8217;s brands.<\/p>\n<p>Many investors were cool to the merger, with Kimberly-Clark shares down nearly 15% on Monday, in part reflecting concern that Tylenol litigation could last years and be expensive.<\/p>\n<p>Kenvue shares closed Wednesday nearly 23% below the takeover price, a sign some investors believe the merger might not close on the original terms.<\/p>\n<p>Kimberly-Clark is not a defendant in Paxton&#8217;s lawsuit. It did not immediately respond to a request for comment.<\/p>\n<p>Paxton filed his lawsuit in Panola County, Texas, which gave Trump 83% of the vote in the presidential election. The attorney general is seeking a U.S. Senate seat in 2026.<\/p>\n<p data-testid=\"SignOff\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__extra_small__8Buss body-module__full_width__kCIGb body-module__extra_small_body__Bfz20 sign-off-module__text__LQAMP\">Reporting by Jonathan Stempel in New York; Editing by Leslie Adler and Lisa Shumaker<\/p>\n<p data-testid=\"Body\" dir=\"ltr\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__regular__qJJtA text-module__small__sph8i body-module__base__o--Cl body-module__small_body__gOmDf article-body-module__element__5eCce article-body-module__trust-badge__5mS3f\">Our Standards: <a data-testid=\"Link\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" href=\"https:\/\/www.thomsonreuters.com\/en\/about-us\/trust-principles.html\" rel=\"noopener nofollow\" class=\"text-module__text__0GDob text-module__dark-grey__UFC18 text-module__medium__2Rl30 text-module__small__sph8i link-module__link__INqxZ link-module__underline_default__-okuC link-module__with-icon__qlg76\">The Thomson Reuters Trust Principles., opens new tab<\/a><\/p>\n<p><a href=\"https:\/\/www.reutersagency.com\/en\/licensereuterscontent\/?utm_medium=rcom-article-media&amp;utm_campaign=rcom-rcp-lead\" target=\"_blank\" dir=\"ltr\" class=\"button-module__link__A3sD0 button-module__secondary__70gBu button-module__round__QDFgq button-module__w_auto__Sem-F\" data-testid=\"LicenceContentButton\" rel=\"nofollow noopener\">Purchase Licensing Rights<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Texas attorney general says Kenvue should conserve cash Nearly $400 million payout planned for November 26 Lawsuit claims&hellip;\n","protected":false},"author":2,"featured_media":166317,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[82519,82499,36586,95749,82794,82500,85474,82502,82803,87652,82802,83630,82531,84147,87219,82779,95750,83113,18,86743,45748,88226,87209,135,87211,84906,19,17,82798,721,462,82506,82565,82524,82575,82507,87647,82790,88152,82780,88227,2765,88228,88229,82508,1540,84909,84910,82510,83002,82998,82558,87202,88225,87204,88230,95751,83126,87203,88231,88232,88137,107,88148,83127],"class_list":{"0":"post-166316","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-amers","9":"tag-bact","10":"tag-biz","11":"tag-chld","12":"tag-clj","13":"tag-cmpny","14":"tag-crim","15":"tag-deal1","16":"tag-destlit","17":"tag-destohlt","18":"tag-destolit","19":"tag-destoprod","20":"tag-destousbsm","21":"tag-destousdnm","22":"tag-destoushem","23":"tag-destoustpm","24":"tag-div","25":"tag-dli","26":"tag-eire","27":"tag-fraud1","28":"tag-gen","29":"tag-genhlt","30":"tag-hea","31":"tag-health","32":"tag-heca","33":"tag-hsehld","34":"tag-ie","35":"tag-ireland","36":"tag-judic","37":"tag-legal","38":"tag-medication","39":"tag-mrg","40":"tag-mtpix","41":"tag-namer","42":"tag-ncyc","43":"tag-news1","44":"tag-nrlpaohlt","45":"tag-nrlpaolit","46":"tag-nrlpaoprod","47":"tag-packageus-top-news","48":"tag-pedmed","49":"tag-phar","50":"tag-phar1","51":"tag-phmr","52":"tag-pol","53":"tag-potus","54":"tag-psnpr","55":"tag-psnpr1","56":"tag-publ","57":"tag-pxp","58":"tag-res","59":"tag-reuters-legal","60":"tag-rhpicommercial-strategy","61":"tag-rhpilawsuits","62":"tag-rhpimergers-acquisitions","63":"tag-rhpipublic-health","64":"tag-sanpro","65":"tag-soci","66":"tag-topicpharma-healthcare-business-health","67":"tag-topicpharma-healthcare-consumer-health","68":"tag-topicpharma-healthcare-policy-regulation","69":"tag-topicworld-us-texas","70":"tag-us","71":"tag-usatx","72":"tag-wash"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/166316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=166316"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/166316\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/166317"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=166316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=166316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=166316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}